partnership
Circassia terminates AstraZeneca partnership in exchange for £150m debt settlement
April 9, 2020Sales and Marketing AstraZeneca, Circassia, partnership, pharma, respiratory
Circassia Pharmaceuticals has announced its decision to break away from a partnership it forged with AstraZeneca UK back in 2017 …
Roche signs multi-billion dollar RNA-targeted drug discovery deal with Arrakis Therapeutics
April 9, 2020Research and Development, Sales and Marketing Arrakis, Roche, partnership, pharma
Roche has signed a new partnership with Arrakis Therapeutics in a bid to drive discovery of RNA-targeted small molecule (rSM) …
Lilly partners with Sitryx in $880m immunometabolism drug development deal
April 1, 2020Research and Development Eli Lilly, Sitryx, partnership, pharma
Eli Lilly and UK firm Sitryx have partnered up in a new drug development and commercialisation deal that could potentially …
Boehringer teams up with OSE in €1.1 billion cancer drug partnership
April 5, 2018Sales and Marketing Boehringer, Cancer, OSE Immunotherapeutics, partnership, pharma
Boehringer Ingelheim and biotech firm OSE Immunotherapeutics have announced that they have entered an exclusive collaboration and license agreement to …
Abcam acquires rights to over 700 Roche products in new licensing deal
January 22, 2018Sales and Marketing Abcam, Roche, partnership, pharma
Roche has entered a licensing agreement Abcam which gives the British biotech exclusive access to the marketing rights for 760 …
Takeda forms “first of its kind” developmental partnership with CRO
September 13, 2016Manufacturing and Production, Research and Development PRA Health Services, Takeda, partnership
Takeda and PRA Health Services have announced a new partnership that will see the Japanese pharma giant transfer 300 staffers …
FDA approves Lilly/Boehringer Ingelheim type-2 diabetes drug
June 1, 2016Research and Development, Sales and Marketing Boehringer Ingelheim, Eli Lilly, FDA, diabetes, jentadueto, jentadueto xr, lilly, partnership, type 2, type-2
The US Food and Drug Administration (FDA) has approved Jentadueto XR (linagliptin and metformin hydrochloride extended release) tablets for the …
Pfizer teams up with Wave Life Sciences for metabolic disease research
May 6, 2016Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Pfizer, metabolic disease, nucelic acid therapies, partnership, wave life sciences
Pfizer (NYSE: PFE) has entered into a research, license and option agreement with Wave Life Sciences (NASDAQ: WVE) for the …
Sun Pharma to partner with ICGEB to develop novel Dengue treatment
May 4, 2016Research and Development Dengue fever, Sun Pharma, collaboration, dengue, development, drug, icgeb, international centre for genetic engineering and biotechnology, partnership, sun pharmaceutical
Sun Pharmaceuticals (BSE: 85715) and the International Centre for Genetic Engineering and Biotechnology (ICGEB) are set to team up to …
AbbVie announces further industry and academic collaborations
April 22, 2016Medical Communications, Research and Development AbbVie, collaboration, commercialisation, cytomx, partnership, research, university of chicago
AbbVie (NYSE: ABBV) has announced further collaborations that will see it partner with industry and academia to develop oncology candidates …
Sanofi reinforces collaboration with Stevenage Bioscience Catalyst with partnering office
April 13, 2016Manufacturing and Production, Research and Development, Sales and Marketing Sanofi, Stevenage Bioscience Catalyst, academia, industry, partnership, pharma, stevenage
Sanofi has reinforced its collaboration with Stevenage Bioscience Catalyst with the opening of a new partnering office. This office will …
Allergan to partner with Heptares in Alzheimer’s disease collaboration
April 7, 2016Manufacturing and Production, Research and Development, Sales and Marketing Allergan, Alzheimer's, Heptares, R&D, collaboration, commercialisation, h1, h4, neurological disorders, partnership, research and development, treatments
Bouncing back quickly from the collapse of the collapse of the Pfizer inversion deal, Allergan (NYSE:AGN) has announced a new …
Phase III trial initiated in Merck and Pfizer partnership for renal cell carcinoma drug
April 6, 2016Research and Development Merck, Pfizer, avelumab, carcinoma, inlyta, javelin, partnership, phase III, renal
The first patient has been treated in the Phase III clinical trial, which sees Merck (ETR: MRK) and Pfizer (NYSE: …
Cancer – dealing with the greatest health challenge of our time
February 4, 2016Manufacturing and Production, Research and Development Cancer, IFPMA, R&D, World Cancer Day, collaboration, partnership
Cancer is one of the greatest health challenges of our time, and a leading cause of death in every corner …
Open access research partnership to ‘crowdsource’ new myeloma drugs
January 27, 2016Research and Development Myeloma UK, Structural Genomics Consortium, collaboration, eric low, myeloma, partnership
Myeloma UK and the Structural Genomics Consortium (SGC) have entered into an open-access research partnership to find new drug targets …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
